ID

26551

Descrizione

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Keywords

versioni (1)
  1. 18/10/17 18/10/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

18 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

study conclusion Ropinirole CR Ropinirole IR Monotherapy 101468/168

Inglese

study conclusion Ropinirole CR Ropinirole IR Monotherapy 101468/168

1 moduli  
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Number
Descrizione

subject number

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
STUDY CONCLUSION
Descrizione

STUDY CONCLUSION

Date of subject completion or withdrawal
Descrizione

Date of subject completion or withdrawal

Tipo di dati

date

Did the subject withdraw from study as a result of this AE?
Descrizione

Withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1710677
UMLS CUI [1,2]
C1518404
Primary reason for withdrawal
Descrizione

Primary reason for withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
Other, specify
Descrizione

Other primary reason for withdrawal

Tipo di dati

text

PREGNANCY INFORMATION
Descrizione

PREGNANCY INFORMATION

Did the subject become pregnant during the study?
Descrizione

If Yes, complete Pregnancy Notification form.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0008976
OVERALL COMPLIANCE
Descrizione

OVERALL COMPLIANCE

Did the subject generally take their morning dose of medication within 2 hours of a meal?
Descrizione

Overall compliance

Tipo di dati

boolean

INVESTIGATOR’S SIGNATURE
Descrizione

INVESTIGATOR’S SIGNATURE

Investigator’s Signature
Descrizione

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Investigator’s name (print)
Descrizione

InvestigatorName

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0035173
UMLS CUI [1,2]
C0600091
UMLS CUI [1,3]
C1547383
Date
Descrizione

Investigator Signature Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Ritorna all'inizio della pagina

Similar models

study conclusion Ropinirole CR Ropinirole IR Monotherapy 101468/168

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
subject number
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
STUDY CONCLUSION
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
Item
Did the subject withdraw from study as a result of this AE?
text
C1710677 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Withdrawal
Code List
Did the subject withdraw from study as a result of this AE?
CL Item
No (N)
CL Item
Yes (Y)
Item
Primary reason for withdrawal
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Primary reason for withdrawal
Code List
Primary reason for withdrawal
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Events forms as appropriate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Other (Z)
Other primary reason for withdrawal
Item
Other, specify
text
Item Group
PREGNANCY INFORMATION
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
pregnancy during study
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not applicable (Not of childbearing potential or male) (Not applicable)
Item Group
OVERALL COMPLIANCE
Overall compliance
Item
Did the subject generally take their morning dose of medication within 2 hours of a meal?
boolean
Item Group
INVESTIGATOR’S SIGNATURE
Investigator Signature
Item
Investigator’s Signature
text
C2346576 (UMLS CUI [1])
InvestigatorName
Item
Investigator’s name (print)
text
C0035173 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C1547383 (UMLS CUI [1,3])
Investigator Signature Date
Item
Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial